Literature DB >> 33405048

Collagen type VIII alpha 2 chain (COL8A2), an important component of the basement membrane of the corneal endothelium, facilitates the malignant development of glioblastoma cells via inducing EMT.

Ying-Xin Cheng1, Lin Xiao2, Yan-Li Yang3, Xiao-Dong Liu1, Xiu-Rong Zhou1, Zhen-Fu Bu1, Pei-Cheng Cao1, Dao-Kui Wang1.   

Abstract

Glioblastoma (GBM) is one of the most lethal tumor of all human cancers. Due to its poor response to chemotherapy and radiotherapy as well as its high rate of recurrence after treatment, the treatment is still undesired. The identification of potential related genes and bio-markers in the development of GBM could provide some new targets for the treatment of GBM. Our purpose in this study was to evaluate the mission of COL8A2 in GBM. Combined with TCGA, Oncomine databases, CGGA, GEPIA website and qRT-PCR analyses, we found that COL8A2 was up-regulated both in GBM tissues and cells compared to the controls. Moreover, the high COL8A2 expression was associated with the shorter overall survival of patients with GBM. The expression of COL8A2 was also positively correlated with metastasis-associated genes including vimentin, snail, slug, MMP2 and MMP7 according to GEPIA website. Knockdown of COL8A2 could suppress the cell proliferation, cell migration and invasion, whereas the overexpression of COL8A2 significantly expedited these processes. What's more, the outcome of western blot analysis manifested that COL8A2 could induced the expression of vimentin, snail, slug, MMP2 and MMP7. Taken together, COL8A2 activated cell proliferation, cell migration and invasion via raising the relative expression of EMT-related proteins in GBM. Therefore, our investigation suggests the oncogenic role of COL8A2 in GBM and provides a potential application of COL8A2 for GBM therapy.

Entities:  

Keywords:  Correlation; Epithelial–mesenchymal transition; Glioblastoma; Invasion; Progression

Mesh:

Substances:

Year:  2021        PMID: 33405048     DOI: 10.1007/s10863-020-09865-1

Source DB:  PubMed          Journal:  J Bioenerg Biomembr        ISSN: 0145-479X            Impact factor:   2.945


  30 in total

1.  PTEN overexpression promotes glioblastoma death through triggering mitochondrial division and inactivating the Akt pathway.

Authors:  Long Bao; Xiang Li; Zhixiong Lin
Journal:  J Recept Signal Transduct Res       Date:  2019-08-29       Impact factor: 2.092

2.  PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.

Authors:  Yu-Cheng Chou; Meng-Ya Chang; Mei-Jen Wang; Fu-Shun Yu; Hsin-Chung Liu; Tomor Harnod; Chih-Huang Hung; Hsu-Tung Lee; Jing-Gung Chung
Journal:  Oncol Rep       Date:  2015-09-08       Impact factor: 3.906

3.  Human SLUG gene organization, expression, and chromosome map location on 8q.

Authors:  M E Cohen; M Yin; W A Paznekas; M Schertzer; S Wood; E W Jabs
Journal:  Genomics       Date:  1998-08-01       Impact factor: 5.736

4.  A randomized trial of bevacizumab for newly diagnosed glioblastoma.

Authors:  Mark R Gilbert; James J Dignam; Terri S Armstrong; Jeffrey S Wefel; Deborah T Blumenthal; Michael A Vogelbaum; Howard Colman; Arnab Chakravarti; Stephanie Pugh; Minhee Won; Robert Jeraj; Paul D Brown; Kurt A Jaeckle; David Schiff; Volker W Stieber; David G Brachman; Maria Werner-Wasik; Ivo W Tremont-Lukats; Erik P Sulman; Kenneth D Aldape; Walter J Curran; Minesh P Mehta
Journal:  N Engl J Med       Date:  2014-02-20       Impact factor: 91.245

5.  Platelet alpha granule depletion: findings in patients with prosthetic heart valves and following cardiopulmonary bypass surgery.

Authors:  C W Pumphrey; J Dawes
Journal:  Thromb Res       Date:  1983-05-01       Impact factor: 3.944

6.  SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression.

Authors:  Victoria J Findlay; Cindy Wang; Lourdes M Nogueira; Katie Hurst; Daniel Quirk; Stephen P Ethier; Kevin F Staveley O'Carroll; Dennis K Watson; E Ramsay Camp
Journal:  Mol Cancer Ther       Date:  2014-09-23       Impact factor: 6.261

7.  Serum levels and tissue expression of matrix metalloproteinase 2 (MMP-2) and tissue inhibitor of metalloproteinases 2 (TIMP-2) in colorectal cancer patients.

Authors:  Magdalena Groblewska; Barbara Mroczko; Mariusz Gryko; Anna Pryczynicz; Katarzyna Guzińska-Ustymowicz; Bogusław Kędra; Andrzej Kemona; Maciej Szmitkowski
Journal:  Tumour Biol       Date:  2014-01-07

8.  Cost-Effectiveness of [18F] Fluoroethyl-L-Tyrosine for Temozolomide Therapy Assessment in Patients With Glioblastoma.

Authors:  Tristan Baguet; Jeroen Verhoeven; Filip De Vos; Ingeborg Goethals
Journal:  Front Oncol       Date:  2019-08-28       Impact factor: 6.244

9.  Interplay of VEGFa and MMP2 regulates invasion of glioblastoma.

Authors:  Jie Gong; Shugan Zhu; Yuan Zhang; Jiangang Wang
Journal:  Tumour Biol       Date:  2014-09-12

10.  Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity.

Authors:  Giovanna Ferrari-Amorotti; Claudia Chiodoni; Fei Shen; Sara Cattelani; Angela Rachele Soliera; Gloria Manzotti; Giulia Grisendi; Massimo Dominici; Francesco Rivasi; Mario Paolo Colombo; Alessandro Fatatis; Bruno Calabretta
Journal:  Neoplasia       Date:  2014-12       Impact factor: 5.715

View more
  1 in total

1.  The Functional Anatomy of the Cornea and Anterior Chamber in Lampreys: Insights From the Pouched Lamprey, Geotria australis (Geotriidae, Agnatha).

Authors:  H Barry Collin; Julian Ratcliffe; Shaun P Collin
Journal:  Front Neuroanat       Date:  2021-12-23       Impact factor: 3.856

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.